Skip to content
Business Segments · Non-cash charges

Prescription Technology Solutions — Non-cash charges

Year-over-year, this metric grew by 142.9%, from $7M to $17M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2020
Last reportedQ4 2026May 8, 2026

How to read this metric

High non-cash charges relative to revenue may suggest heavy investment in intangible assets or technology platforms, impacting GAAP profitability.

Detailed definition

Captures expenses recognized in the income statement that do not involve an immediate cash outflow, specifically within...

Peer comparison

Standard accounting metric used to reconcile GAAP earnings to cash flow, common across all public companies.

Metric ID: mck_segment_prescription_technology_solutions_non_cash_charges

Historical Data

12 periods
 Q1 '22Q1 '23Q1 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26
Value$17M$5M$0$0$1M$1M$0$7M$0$0$0$17M
QoQ Change-70.6%-100.0%+0.0%-100.0%-100.0%
YoY Change-70.6%-100.0%-100.0%-100.0%+142.9%
Range$0$17M
CAGR+0.0%
Avg YoY Growth-45.5%
Median YoY Growth-100.0%

Frequently Asked Questions

What is McKesson's prescription technology solutions — non-cash charges?
McKesson (MCK) reported prescription technology solutions — non-cash charges of $17M in Q1 2026.
How has McKesson's prescription technology solutions — non-cash charges changed year-over-year?
McKesson's prescription technology solutions — non-cash charges increased by 142.9% year-over-year, from $7M to $17M.
What does prescription technology solutions — non-cash charges mean?
Expenses that reduce reported earnings but do not involve actual cash payments within the technology solutions segment.